House Oversight Committee Chairman James Comer (R-KY). Photo: Christine Schiffner/ALM
A House panel this week advanced a bipartisan bill that would ban pharmacy benefit managers from charging fees based on drug list prices. The House Committee on Oversight and Accountability voted 29-11 to approve the so-called Delinking Revenue from Unfair Gouging (DRUG) Act.
"Rarely a day goes by that I don't hear from constituents concerned about the high cost of prescription drugs," committee Chair James Comer, R-Ky., said. "I am pleased the committee is considering such important legislation to reign in these PBMs and curb these abusive practices."
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
